Search research articles
Contact Us
Filters
Showing results (301-310 of 391) with videos related to
Page
of 40
Sort By:
JTO Clinical and Research Reports
|
January 26, 2026
First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From <i>ALK</i>-Rearranged NSCLC: Case Report
Kaiwen Wang, Ceylan Altintas Taslic, Patricia de Groot, et al.
The Oncologist
|
March 12, 2017
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common <i>CDKN2A</i> Alteration
Julia A Elvin, Laurie M Gay, Rita Ort, et al.
CA: a Cancer Journal for Clinicians
|
June 17, 2023
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Developmental Cell
|
July 20, 2023
Ribosomal RNA 2'-O-methylation dynamics impact cell fate decisions
Sophia J Häfner, Martin D Jansson, Kübra Altinel, et al.
Cancer
|
January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Human Pathology
|
October 29, 2017
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study
Hwajeong Lee, Tony El Jabbour, Sanaz Ainechi, et al.
Clinical and Experimental Immunology
|
November 11, 2023
CD3 downregulation identifies high-avidity human CD8 T cells
Genevieve T Clutton, Ann Marie K Weideman, Melissa A Mischell, et al.
Cancer & Metabolism
|
September 24, 2021
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Kasey R Cargill, C Allison Stewart, Elizabeth M Park, et al.
Cancer
|
June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies
Jeffrey S Ross, Laurie M Gay, Kai Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2018
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, et al.
Page
of 40
Search research articles
Search
Showing results (301-310 of 391) with videos related to
Sort By:
Page
of 40
JTO Clinical and Research Reports
|
January 26, 2026
First Report of Response to Tarlatamab in a Patient With Histologic-Transformed SCLC From <i>ALK</i>-Rearranged NSCLC: Case Report
Kaiwen Wang, Ceylan Altintas Taslic, Patricia de Groot, et al.
The Oncologist
|
March 12, 2017
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common <i>CDKN2A</i> Alteration
Julia A Elvin, Laurie M Gay, Rita Ort, et al.
CA: a Cancer Journal for Clinicians
|
June 17, 2023
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Developmental Cell
|
July 20, 2023
Ribosomal RNA 2'-O-methylation dynamics impact cell fate decisions
Sophia J Häfner, Martin D Jansson, Kübra Altinel, et al.
Cancer
|
January 17, 2018
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
Jeffrey S Ross, Marwan Fakih, Siraj M Ali, et al.
Human Pathology
|
October 29, 2017
General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study
Hwajeong Lee, Tony El Jabbour, Sanaz Ainechi, et al.
Clinical and Experimental Immunology
|
November 11, 2023
CD3 downregulation identifies high-avidity human CD8 T cells
Genevieve T Clutton, Ann Marie K Weideman, Melissa A Mischell, et al.
Cancer & Metabolism
|
September 24, 2021
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Kasey R Cargill, C Allison Stewart, Elizabeth M Park, et al.
Cancer
|
June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies
Jeffrey S Ross, Laurie M Gay, Kai Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2018
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, et al.
Page
of 40